Biotage Will Acquire Astrea Bio Business In $190M Stock Deal
Swedish life sciences business Biotage AB will acquire Astrea Bioseparations — the operating company of the Gamma Biosciences platform created by global investment firm KKR, which is being advised by Gibson Dunn...To view the full article, register now.
Already a subscriber? Click here to view full article